Learn About Angiosarcoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Memorial Sloan Kettering Cancer Center
William Tap is a Hematologist Oncology expert in New York, New York. Tap has been practicing medicine for over 23 years and is rated as an Elite expert by MediFind in the treatment of Angiosarcoma. He is also highly rated in 35 other conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Angiosarcoma, Synovial Sarcoma, Tissue Biopsy, and Liver Embolization. Tap is currently accepting new patients.
Memorial Sloan Kettering Cancer Center
Sandra Dangelo is an Oncologist in New York, New York. Dangelo has been practicing medicine for over 19 years and is rated as an Elite expert by MediFind in the treatment of Angiosarcoma. She is also highly rated in 35 other conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Synovial Sarcoma, and Liver Embolization. Dangelo is currently accepting new patients.
University of Texas System
Physicians Referral Service
Vinod Ravi is an Oncologist in Houston, Texas. Ravi has been practicing medicine for over 25 years and is rated as an Elite expert by MediFind in the treatment of Angiosarcoma. He is also highly rated in 34 other conditions, according to our data. His top areas of expertise are Angiosarcoma, Adult Soft Tissue Sarcoma, Leiomyosarcoma, Heart Tumor, and Salpingo-Oophorectomy. Ravi is currently accepting new patients.
Summary: This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for the following cohorts based on condition: Epithelial tumors of nasal cavi...
Summary: This phase II trial studies how well paclitaxel with and without nivolumab works in treating patients with soft tissue sarcoma that have not received taxane drugs, and how well nivolumab and cabozantinib work in treating taxane pretreated patients with soft tissue sarcoma. Nivolumab works through the body's immune system to help the immune system act against tumor cells. Chemotherapy drugs, such a...